JAFRAL CEO Frenk Smrekar to Host Workshop at Targeting Phage Therapy Congress 2025

JAFRAL is excited to announce that our CEO, Frenk Smrekar, will host a dedicated workshop at this year’s Targeting Phage Therapy Congress in Berlin, June 10–11, 2025, titled:

"How to Produce, Manufacture, and Bring Phage Products to Market"

With the growing global focus on bacteriophages as a solution to rising antibiotic resistance, this workshop will provide attendees with practical insights into the development, manufacturing, and commercialization of phage-based products.

We invite scientists, biotech innovators, and pharmaceutical leaders to join the discussion, share expertise, and contribute to shaping the future of phage therapy. The session promises to be an invaluable opportunity for knowledge exchange, networking, and exploring collaborative pathways in this rapidly evolving field.

As a sponsor of the congress, JAFRAL is proud to engage with the global phage community, offering attendees the chance to connect with our team, discuss phage production, and explore potential collaborations.

‍